Top-Rated StocksTop-RatedNASDAQ:DICE DICE Therapeutics (DICE) News Today $32.81 -0.34 (-1.03%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$32.14▼$33.6950-Day Range$25.86▼$38.2452-Week Range$12.64▼$45.99Volume212,713 shsAverage Volume452,437 shsMarket Capitalization$1.57 billionP/E RatioN/ADividend YieldN/APrice Target$62.60 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get DICE Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DICE and its competitors with MarketBeat's FREE daily newsletter. Email Address DICE Media Mentions By Week DICE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DICE News Sentiment▼0.660.75▲Average Medical News Sentiment DICE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DICE Articles This Week▼163▲DICE Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAigen Investment Management LP Makes New Investment in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - May 26 at 7:29 AMDICE Therapeutics (NASDAQ:DICE) Now Covered by Wells Fargo & Companyamericanbankingnews.com - May 26 at 3:58 AMWells Fargo Initiates Coverage of DICE Therapeutics (DICE) with Equal-Weight Recommendationmsn.com - May 25 at 1:18 AMDICE Therapeutics equalweight at Wells Fargo on lack of catalystsmsn.com - May 24 at 3:16 PMH.C. Wainwright Sticks to Its Hold Rating for Sana Biotechnology (SANA)markets.businessinsider.com - May 24 at 10:16 AMDICE Therapeutics (NASDAQ:DICE) Shares Gap Up to $32.66americanbankingnews.com - May 24 at 6:30 AMArizona State Retirement System Buys New Shares in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - May 24 at 4:33 AMDICE Therapeutics psoriasis treatment has blockbuster potential, analysts sayproactiveinvestors.com - May 23 at 7:17 PMDICE Therapeutics (NASDAQ:DICE) Receives New Coverage from Analysts at Canaccord Genuity Groupamericanbankingnews.com - May 23 at 3:00 AMCanaccord Genuity Initiates Coverage of DICE Therapeutics (DICE) with Buy Recommendationmsn.com - May 23 at 12:41 AMH.C. Wainwright Sticks to Their Buy Rating for Gracell Biotechnologies (GRCL)markets.businessinsider.com - May 22 at 2:39 PMState Board of Administration of Florida Retirement System Reduces Stake in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - May 22 at 4:54 AMEquities Analysts Issue Forecasts for DICE Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:DICE)americanbankingnews.com - May 19 at 3:36 AMH.C. Wainwright Sticks to Its Buy Rating for MiNK Therapeutics (INKT)markets.businessinsider.com - May 18 at 12:35 PMAnalysts Set DICE Therapeutics, Inc. (NASDAQ:DICE) Price Target at $64.63americanbankingnews.com - May 18 at 2:58 AMEquities Analysts Set Expectations for DICE Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:DICE)marketbeat.com - May 17 at 7:26 AMTrevi Therapeutics (TRVI) Receives a Rating Update from a Top Analystmarkets.businessinsider.com - May 15 at 7:05 AMDice Therapeutics (DICE) Receives a Rating Update from a Top Analystmarkets.businessinsider.com - May 15 at 7:05 AMDICE Therapeutics, Inc. (NASDAQ:DICE) Receives Consensus Recommendation of "Buy" from Analystsmarketbeat.com - May 15 at 1:15 AMHC Wainwright & Co. Reiterates DICE Therapeutics (DICE) Buy Recommendationmsn.com - May 12 at 11:47 PMDICE Therapeutics, Inc.: DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlightsfinanznachrichten.de - May 12 at 8:45 AMH.C. Wainwright Remains a Buy on Dice Therapeutics (DICE)markets.businessinsider.com - May 12 at 8:45 AMDICE Therapeutics, Inc. (NASDAQ:DICE) Director Sells $3,238,575.47 in Stockamericanbankingnews.com - May 12 at 4:38 AMRecap: DICE Therapeutics Q1 Earningsmsn.com - May 11 at 8:39 PMDICE Therapeutics GAAP EPS of -$0.54seekingalpha.com - May 11 at 8:39 PMDICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlightsfinance.yahoo.com - May 11 at 8:39 PMDICE Therapeutics Board Member Trades Company's Stockbenzinga.com - May 10 at 3:11 PMTD Asset Management Inc Boosts Position in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - May 9 at 5:25 AMDICE Therapeutics: Worth A Roll At The Right Pricemsn.com - May 8 at 10:42 AMInsider Selling: DICE Therapeutics, Inc. (NASDAQ:DICE) CMO Sells $365,400.00 in Stockamericanbankingnews.com - May 8 at 6:06 AMInsider Selling: DICE Therapeutics, Inc. (NASDAQ:DICE) CFO Sells $685,312.50 in Stockamericanbankingnews.com - May 8 at 5:32 AMDICE Therapeutics, Inc. (NASDAQ:DICE) CEO Sells $499,977.00 in Stockamericanbankingnews.com - May 8 at 5:32 AMZurcher Kantonalbank Zurich Cantonalbank Takes Position in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - May 8 at 4:39 AMDICE Therapeutics, Inc. (NASDAQ:DICE) CMO Sells $365,400.00 in Stockmarketbeat.com - May 5 at 5:52 PMFox Run Management L.L.C. Takes $309,000 Position in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - May 5 at 7:04 AMSG Americas Securities LLC Makes New $518,000 Investment in DICE Therapeutics, Inc. (NASDAQ:DICE)marketbeat.com - May 4 at 5:02 AMDICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conferencefinance.yahoo.com - May 3 at 8:34 PMDice Therapeutics (DICE) Gets a Buy from H.C. Wainwrightmarkets.businessinsider.com - April 25 at 2:08 PM5,000 Shares in DICE Therapeutics, Inc. (NASDAQ:DICE) Purchased by DekaBank Deutsche Girozentralemarketbeat.com - April 25 at 4:47 AMDICE Therapeutics, Inc. (NASDAQ:DICE) Receives Average Rating of "Buy" from Analystsamericanbankingnews.com - April 25 at 2:12 AMTop 5 Stocks Activist Investors Are Targetinginsidermonkey.com - April 21 at 4:26 PMDICE Therapeutics, Inc. (NASDAQ:DICE) Insider John R. Jacobsen Sells 16,392 Sharesamericanbankingnews.com - April 20 at 6:32 AMDICE Therapeutics, Inc. (NASDAQ:DICE) Given Average Recommendation of "Buy" by Analystsmarketbeat.com - April 20 at 4:44 AMJohn R. Jacobsen Sells 773 Shares of DICE Therapeutics, Inc. (NASDAQ:DICE) Stockamericanbankingnews.com - April 6 at 6:06 AMDICE Therapeutics, Inc. (NASDAQ:DICE) Short Interest Up 13.2% in Marchmarketbeat.com - April 3 at 2:42 AMInsider Buying: DICE Therapeutics, Inc. (NASDAQ:DICE) Director Buys $1,949,921.22 in Stockamericanbankingnews.com - April 2 at 4:52 AMDICE Therapeutics (NASDAQ:DICE) Now Covered by Analysts at Needham & Company LLCamericanbankingnews.com - April 1 at 9:34 AMJohn R. Jacobsen Sells 500 Shares of DICE Therapeutics, Inc. (NASDAQ:DICE) Stockamericanbankingnews.com - April 1 at 8:08 AMDICE Therapeutics (NASDAQ:DICE) Coverage Initiated at Needham & Company LLCmarketbeat.com - March 31 at 7:45 AMDICE Therapeutics, Inc. (NASDAQ:DICE) Receives $65.86 Consensus Price Target from Analystsamericanbankingnews.com - March 31 at 2:58 AM Get DICE Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DICE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aurinia Pharmaceuticals News Zentalis Pharmaceuticals News Ironwood Pharmaceuticals News Geron News FibroGen News Verona Pharma News Xencor News Agios Pharmaceuticals News Syndax Pharmaceuticals News Keros Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:DICE) was last updated on 5/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DICE Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.